Nanoparticles (NPs) are playing a progressively more significant role in multimodal and multifunctional imaging [1] . NPs have been used as contrast agents (CAs) for magnetic resonance and optical imaging studies [2] . More recently, X-ray computed tomography (CT) CAs based on heavy metal NPs of gold, tantalum and bismuth have been reported [3] . We herein report tungsten (z = 74) oxide (WO3), zero valent bismuth (z = 83) ZV-Bi NPs stabilized and biocompatibilized with organic ligands for in vivo use as CT contrast agents.
Nanoparticles (NPs) are playing a progressively more significant role in multimodal and multifunctional imaging [1] . NPs have been used as contrast agents (CAs) for magnetic resonance and optical imaging studies [2] . More recently, X-ray computed tomography (CT) CAs based on heavy metal NPs of gold, tantalum and bismuth have been reported [3] . We herein report tungsten (z = 74) oxide (WO3), zero valent bismuth (z = 83) ZV-Bi NPs stabilized and biocompatibilized with organic ligands for in vivo use as CT contrast agents.
Uniformly sized WO3 NPs (2-80 nm dia.) were prepared by water-in-oil (w/o) emulsion method [4] . The particles were then coated with a mixture of tetraethyl orthosilicate (TEOS) and 2-[methoxy(polyethyleneoxy) 9-12 propyl] trimethoxysilane (PEG-silane) to make them dispersible in water by adding TEOS/PEG-silane mixture to the emulsion containing nanoparticles, followed by ammonium hydroxide to hydrolyze TEOS or PEG-silane and deposit SiO2 layer(s) [5] . Particles were isolated by breaking the emulsion with excess of acetone. It was difficult to achieve narrow size distribution and uniform silica coating for bigger particles (Fig. 1) , and the particles had surfactant entrapped in the silica layer. Also, it is difficult to produce WO3 NPs on a large scale by this method.
Direct reduction of Bi(III) salts in water a with large excess of strong reducing agent like sodium borohydride (BH4 1- , it is unstable under acidic conditions) in the presence of thiols and acetic acid (to keep thiols protonated) (Fig. 2) resulted in ligand stabilized ZV-BiNPs. The thiol B (Fig. 2 ) gave 1-4 nm NPs and thiol D gave 4-13 nm NPs. Under basic conditions unique 30-70 nm long nanoassemblies (BiNAs), of ZV-BiNPs (5.21±0.6 nm) were formed with hydroxy terminated thiols (Fig. 3C) . We attribute the formation of BiNAs to ligand hydrophobicity and the interaction of terminal -OH groups based on the estimated ligand lengths and average width of the BiNAs. The HR-TEM confirms crystalline nature of both WO3-and ZVBi-NPs (Fig. 1B and 3D ).
The WO3-NPs with a thin SiO2 coating were toxic, probably due to release of tungstate under physiological conditions, while Bi-NPs were oxidatively unstable and aggregated in isotonic buffers (change of color from black to gray-white). Therefore, we prepared WO3-and ZVBi-silica hybrid NPs by TEOS hydrolysis method (Fig. 4) . Although, the WO3-and ZVBi-silica hybrid particles are useful blood pool agents their long-term whole body retention is a main concern for their in vivo use.
The new NPs can be functionalized a mixture of silanes A and A' ( Fig. 2 ; 75% to 25% surface coverage) for further cross-linking to other CAs agents for multimodal and for attachment to targeting agents for molecular imaging [1] [2] [3] [6] .
